These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18840614)

  • 1. Transcription enhancer factor 3 (TEF3) mediates the expression of Down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells.
    Liu X; Zhao D; Qin L; Li J; Zeng H
    J Biol Chem; 2008 Dec; 283(49):34159-67. PubMed ID: 18840614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor.
    Liu X; Zhao D; James L; Li J; Zeng H
    FASEB J; 2011 Apr; 25(4):1188-97. PubMed ID: 21169383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway.
    Qin L; Zhao D; Liu X; Nagy JA; Hoang MV; Brown LF; Dvorak HF; Zeng H
    Mol Cancer Res; 2006 Nov; 4(11):811-20. PubMed ID: 17114339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel axis of YAP1, transcription enhancer factor 3 and Down Syndrome Candidate Region 1 isoform 1L is a common signaling pathway downstream of several angiogenic factors.
    Cui P; Liu X; Zhao K; Hou S; Chen C; Zhao D; Zeng H
    Microvasc Res; 2020 May; 129():103955. PubMed ID: 31733305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis.
    Hou S; Niu G; Liu X; Bourbon PM; Zhang D; Cui P; Zhao K; Zhao D; Zeng H
    Microvasc Res; 2021 Nov; 138():104209. PubMed ID: 34146582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells.
    Chen C; Cui P; Zhao K; Niu G; Hou S; Zhao D; Zeng H
    Microvasc Res; 2022 Mar; 140():104305. PubMed ID: 34958805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?
    Yao YG; Duh EJ
    Biochem Biophys Res Commun; 2004 Aug; 321(3):648-56. PubMed ID: 15358155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis.
    Gollogly LK; Ryeom SW; Yoon SS
    J Surg Res; 2007 Sep; 142(1):129-36. PubMed ID: 17610901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells.
    Hesser BA; Liang XH; Camenisch G; Yang S; Lewin DA; Scheller R; Ferrara N; Gerber HP
    Blood; 2004 Jul; 104(1):149-58. PubMed ID: 15016650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear localization of TEF3-1 promotes cell cycle progression and angiogenesis in cancer.
    Teng K; Deng C; Xu J; Men Q; Lei T; Di D; Liu T; Li W; Liu X
    Oncotarget; 2016 Mar; 7(12):13827-41. PubMed ID: 26885617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depolarization of neural cells induces transcription of the Down syndrome critical region 1 isoform 4 via a calcineurin/nuclear factor of activated T cells-dependent pathway.
    Cano E; Canellada A; Minami T; Iglesias T; Redondo JM
    J Biol Chem; 2005 Aug; 280(33):29435-43. PubMed ID: 15975916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of Down Syndrome Critical Region 1 Isoform 4 in Ischemic Retinal Ganglion Cells Displays Anti-Angiogenic Properties Via NFATc1-Dependent Pathway.
    Xu Y; Yang B; Hu Y; Lu L; Lu X; Wang J; Shu Q; Cheng Q; Yu S; Xu F; Huang J; Liang X
    Mol Neurobiol; 2017 Oct; 54(8):6556-6571. PubMed ID: 27734335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RTEF-1, a novel transcriptional stimulator of vascular endothelial growth factor in hypoxic endothelial cells.
    Shie JL; Wu G; Wu J; Liu FF; Laham RJ; Oettgen P; Li J
    J Biol Chem; 2004 Jun; 279(24):25010-6. PubMed ID: 15073166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the transcriptional activation domains of human TEF3-1 (transcription enhancer factor 3 isoform 1).
    Qiao C; Jiang Y; Deng C; Huang Z; Teng K; Chen L; Liu X
    Arch Biochem Biophys; 2015 Mar; 569():54-61. PubMed ID: 25687649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down syndrome candidate region 1,a downstream target of VEGF, participates in endothelial cell migration and angiogenesis.
    Iizuka M; Abe M; Shiiba K; Sasaki I; Sato Y
    J Vasc Res; 2004; 41(4):334-44. PubMed ID: 15263820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of DSCR1 to disomy in the trisomy 16 mouse model of Down syndrome does not correct cardiac or craniofacial development anomalies.
    Lange AW; Rothermel BA; Yutzey KE
    Dev Dyn; 2005 Jul; 233(3):954-63. PubMed ID: 15906378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
    Shin J; Lee JC; Baek KH
    Cancer Lett; 2014 Jan; 342(1):70-81. PubMed ID: 24051307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.
    Fuentes JJ; Genescà L; Kingsbury TJ; Cunningham KW; Pérez-Riba M; Estivill X; de la Luna S
    Hum Mol Genet; 2000 Jul; 9(11):1681-90. PubMed ID: 10861295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth.
    Ryeom S; Baek KH; Rioth MJ; Lynch RC; Zaslavsky A; Birsner A; Yoon SS; McKeon F
    Cancer Cell; 2008 May; 13(5):420-31. PubMed ID: 18455125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia.
    Zaccagnini G; Gaetano C; Della Pietra L; Nanni S; Grasselli A; Mangoni A; Benvenuto R; Fabrizi M; Truffa S; Germani A; Moretti F; Pontecorvi A; Sacchi A; Bacchetti S; Capogrossi MC; Farsetti A
    J Biol Chem; 2005 Apr; 280(15):14790-8. PubMed ID: 15687494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.